0.25mg DRSP / 0.5mg E2 (BAY86-4891) + 0.5mg NETA / 1.0mg E2 (Activella)

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Postmenopause

Conditions

Postmenopause

Trial Timeline

Aug 1, 2007 → Aug 1, 2009

NCT ID

NCT00522873

About 0.25mg DRSP / 0.5mg E2 (BAY86-4891) + 0.5mg NETA / 1.0mg E2 (Activella)

0.25mg DRSP / 0.5mg E2 (BAY86-4891) + 0.5mg NETA / 1.0mg E2 (Activella) is a phase 3 stage product being developed by Bayer for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00522873. Target conditions include Postmenopause.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00522873	Phase 3	Completed	Aug 1, 2007	Aug 1, 2009	Postmenopause

Competing Products

16 competing products in Postmenopause

See all competitors

Product	Company	Stage	Hype Score
Comparator: placebo + Comparator: Estrace	Merck	Phase 1	33
bazedoxifene/conjugated estrogens combination tablet	Pfizer	Phase 1	32
Bazedoxifene 10 mg/CE 0.625 mg + Bazedoxifene 20 mg/CE 0.625 mg + Bazedoxifene 40 mg/CE 0.625 mg + Bazedoxifene 10 mg/CE 0.45 mg + Bazedoxifene 20 mg/CE 0.45 mg + Bazedoxifene 40 mg/CE 0.45 mg + Raloxifene 60 mg + Placebo	Pfizer	Pre-clinical	22
Premarin	Pfizer	Pre-clinical	22
Bazedoxifene and conjugated estrogens	Pfizer	Phase 1	32
Premarin/MPA + Premarin/MPA + Provera 10 mg	Pfizer	Phase 1	32
Bazedoxifene/conjugated estrogens	Pfizer	Phase 1	32
Premarin	Pfizer	Phase 1	32
bazedoxifene BZA-20	Pfizer	Phase 3	76
Trimegestone + 17b Estradiol	Pfizer	Approved	84
Premarin/MPA 0.45 mg/1.5 mg	Pfizer	Phase 1	32
Conjugated Estrogen Cream (Premarin®)	Pfizer	Pre-clinical	22
Estradiol/DRSP (Angeliq, BAY86-4891)	Bayer	Approved	82
E2/LNG oral (Wellnara, BAY86-5029)	Bayer	Pre-clinical	20
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM)	Bayer	Phase 2	49
Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate	Organon	Approved	80

Other Products from Bayer

TelmisartanApproved

Clotrimazole vaginal tablet + FluconazoleApproved

Levitra (Vardenafil, BAY38-9456)Approved

Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved

Rivaroxaban 20 MG + WarfarinApproved